Learn / AUPH
NASDAQ: AUPH
Aurinia Pharmaceuticals (AUPH) stock, explained like you're 5
Aurinia Pharmaceuticals trades on the Nasdaq under the ticker AUPH. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2.2 billion dollars.
- Ticker
- AUPH
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 2.2 billion dollars
Is Aurinia Pharmaceuticals a small, medium or large cap company?
No. Aurinia Pharmaceuticals is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2.2 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Aurinia Pharmaceuticals makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves AUPH stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- AUPH Stock Rallies 6% After Hours Here’s Why (Stocktwits)
- Is Aurinia Pharmaceuticals Inc. (AUPH) A Good Stock To Buy Now? (Yahoo Finance)
- Responsive Playbooks and the AUPH Inflection (Stock Traders Daily)
- Aurinia Pharmaceuticals stock heads toward November 3, 2026 earnings (ad-hoc-news.de)
- Aurinia's First FDA Approved Oral Therapy for Lupus Nephritis Generates $79.4M (Stock Titan)
Follow AUPH in your daily brief
Each trading day at 5 PM ET we post what happened to Aurinia Pharmaceuticals and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow AUPH
Questions about Aurinia Pharmaceuticals stock
What does Aurinia Pharmaceuticals do?
Aurinia Pharmaceuticals trades on the Nasdaq under the ticker AUPH. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2.2 billion dollars.
What is the ticker symbol for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals trades under the ticker AUPH on the Nasdaq.
What is Aurinia Pharmaceuticals's market cap?
Aurinia Pharmaceuticals is a mid cap stock with a market cap of about 2.2 billion dollars.
How does Aurinia Pharmaceuticals make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves AUPH stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow AUPH stock every day?
Add AUPH to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.